Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels

ClinicalTrials.gov ID: NCT00327691

Public ClinicalTrials.gov record NCT00327691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of this study is to determine the degree of additional reduction in cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the currently accepted minimum target level for patients with pre-existing CHD. Secondary objectives include the safety profile of this treatment strategy, its cost-effectiveness, effect on other atherosclerotic-related events and procedures, and total mortality.

Study identification

NCT ID
NCT00327691
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
8,600 participants

Conditions and interventions

Eligibility (public fields only)

Age range
35 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1998 (Type not available)
Primary completion
Not listed
Completion
Aug 2004 (Type not available)
Last update posted
May 3, 2007

1998 – 2004

United States locations

U.S. sites
181
U.S. states
40
U.S. cities
132
Facility City State ZIP Site status
Pfizer Investigational Site Alabaster Alabama 35007 —
Pfizer Investigational Site Birmingham Alabama 35205-4785 —
Pfizer Investigational Site Birmingham Alabama 35213 —
Pfizer Investigational Site Birmingham Alabama 35294-2041 —
Pfizer Investigational Site Hoover Alabama 35216 —
Pfizer Investigational Site Montgomery Alabama 36117 —
Pfizer Investigational Site Mesa Arizona 85202 —
Pfizer Investigational Site Mesa Arizona 85206 —
Pfizer Investigational Site Burbank California 91505 —
Pfizer Investigational Site Camp Pendleton California 92055 —
Pfizer Investigational Site Fresno California 93703 —
Pfizer Investigational Site La Jolla California 92037 —
Pfizer Investigational Site Loma Linda California 92354 —
Pfizer Investigational Site Los Angeles California 90017-2395 —
Pfizer Investigational Site Los Angeles California 90048 —
Pfizer Investigational Site Modesto California 95350 —
Pfizer Investigational Site Pasadena California 91105 —
Pfizer Investigational Site Rancho Mirage California 92270 —
Pfizer Investigational Site San Diego California 92134-3303 —
Pfizer Investigational Site San Francisco California 94143-0130 —
Pfizer Investigational Site San Francisco California 94143-0326 —
Pfizer Investigational Site Santa Rosa California 95403 —
Pfizer Investigational Site Stanford California — —
Pfizer Investigational Site Aurora Colorado 80012 —
Pfizer Investigational Site Denver Colorado 80203 —
Pfizer Investigational Site Denver Colorado 80218 —
Pfizer Investigational Site Denver Colorado 80220 —
Pfizer Investigational Site Bridgeport Connecticut 06610 —
Pfizer Investigational Site Hartford Connecticut 06102 —
Pfizer Investigational Site New Britain Connecticut 06053 —
Pfizer Investigational Site Newark Delaware 19718 —
Pfizer Investigational Site Washington D.C. District of Columbia 20037 —
Pfizer Investigational Site Clearwater Florida 33756 —
Pfizer Investigational Site Gainsville Florida 32608 —
Pfizer Investigational Site Gainsville Florida 32610 —
Pfizer Investigational Site Hollywood Florida 33021 —
Pfizer Investigational Site Inverness Florida 34452 —
Pfizer Investigational Site Lakeland Florida 33805 —
Pfizer Investigational Site Miami Florida 33173 —
Pfizer Investigational Site Miami Florida 33176 —
Pfizer Investigational Site Ocala Florida 34474 —
Pfizer Investigational Site Orlando Florida 32803 —
Pfizer Investigational Site Port Charlotte Florida 33952 —
Pfizer Investigational Site Sarasota Florida 34239 —
Pfizer Investigational Site Stuart Florida 34996 —
Pfizer Investigational Site Tamarac Florida 33321 —
Pfizer Investigational Site The Villages Florida 32159 —
Pfizer Investigational Site Atlanta Georgia 30309 —
Pfizer Investigational Site Canton Georgia 30114 —
Pfizer Investigational Site Berwyn Illinois 60402 —
Pfizer Investigational Site Blue Island Illinois 60406 —
Pfizer Investigational Site Chicago Illinois 60610 —
Pfizer Investigational Site Chicago Illinois 60611 —
Pfizer Investigational Site Du Quoin Illinois 62832 —
Pfizer Investigational Site Evanston Illinois 60201 —
Pfizer Investigational Site Lake Forest Illinois 60045 —
Pfizer Investigational Site Marion Illinois 62959 —
Pfizer Investigational Site Pekin Illinois 61554 —
Pfizer Investigational Site Peoria Illinois 61603 —
Pfizer Investigational Site Peoria Illinois 61614 —
Pfizer Investigational Site Beech Grove Indiana 46107 —
Pfizer Investigational Site Evansville Indiana 47710 —
Pfizer Investigational Site Fort Wayne Indiana 46805 —
Pfizer Investigational Site Fort Wayne Indiana 46825 —
Pfizer Investigational Site Jeffersonville Indiana 47130 —
Pfizer Investigational Site Scottsburg Indiana 47170 —
Pfizer Investigational Site Des Moines Iowa 50314 —
Pfizer Investigational Site Iowa City Iowa 52242 —
Pfizer Investigational Site Kansas City Kansas 66160-7200 —
Pfizer Investigational Site Lathe Kansas 66061 —
Pfizer Investigational Site Overland Park Kansas 66213 —
Pfizer Investigational Site Wichita Kansas 67220 —
Pfizer Investigational Site Edgewood Kentucky 41017 —
Pfizer Investigational Site Erlanger Kentucky 41018 —
Pfizer Investigational Site Louisville Kentucky 40202 —
Pfizer Investigational Site Marrero Louisiana 70072 —
Pfizer Investigational Site New Orleans Louisiana 70112 —
Pfizer Investigational Site New Orleans Louisiana 70121 —
Pfizer Investigational Site Portland Maine 04102 —
Pfizer Investigational Site Baltimore Maryland 21201 —
Pfizer Investigational Site Baltimore Maryland 21204 —
Pfizer Investigational Site Baltimore Maryland 21205 —
Pfizer Investigational Site Baltimore Maryland 21208 —
Pfizer Investigational Site Baltimore Maryland 21218 —
Pfizer Investigational Site Baltimore Maryland 21224 —
Pfizer Investigational Site Baltimore Maryland 21228 —
Pfizer Investigational Site Baltimore Maryland 21229 —
Pfizer Investigational Site Baltimore Maryland 21237 —
Pfizer Investigational Site Baltimore Maryland 21287 —
Pfizer Investigational Site Bel Air Maryland 21014 —
Pfizer Investigational Site Westminster Maryland 21157 —
Pfizer Investigational Site Boston Massachusetts 02111 —
Pfizer Investigational Site Boston Massachusetts 02215 —
Pfizer Investigational Site Burlington Massachusetts 1805 —
Pfizer Investigational Site Dearborn Michigan 48126 —
Pfizer Investigational Site Detroit Michigan 48202 —
Pfizer Investigational Site Farmington Hill Michigan 48336 —
Pfizer Investigational Site Sterling Heights Michigan 48310 —
Pfizer Investigational Site West Bloomfield Michigan 48322 —
Pfizer Investigational Site Duluth Minnesota 55805 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Maplewood Minnesota 55109 —
Pfizer Investigational Site Minneapolis Minnesota 55455 —
Pfizer Investigational Site Saint Paul Minnesota 55102 —
Pfizer Investigational Site Kansas City Missouri 64111 —
Pfizer Investigational Site St Louis Missouri 63104 —
Pfizer Investigational Site St Louis Missouri 63110-0205 —
Pfizer Investigational Site St Louis Missouri 63110 —
Pfizer Investigational Site St Louis Missouri 63117 —
Pfizer Investigational Site St Louis Missouri 63141 —
Pfizer Investigational Site Papillion Nebraska 68046 —
Pfizer Investigational Site Manchester New Hampshire 03102 —
Pfizer Investigational Site New Brunswick New Jersey 08901 —
Pfizer Investigational Site Albany New York 12208 —
Pfizer Investigational Site Brooklyn New York 11203 —
Pfizer Investigational Site Hawthorne New York 10535 —
Pfizer Investigational Site Manlius New York 13104 —
Pfizer Investigational Site New York New York 10021 —
Pfizer Investigational Site New York New York 10029 —
Pfizer Investigational Site New York New York 10032 —
Pfizer Investigational Site Rochester New York 14607 —
Pfizer Investigational Site Rochester New York 14618 —
Pfizer Investigational Site Rochester New York 14621 —
Pfizer Investigational Site Syracuse New York 13202 —
Pfizer Investigational Site Syracuse New York 13210 —
Pfizer Investigational Site Valhalla New York 10595 —
Pfizer Investigational Site Asheville North Carolina 28803 —
Pfizer Investigational Site Durham North Carolina 27710 —
Pfizer Investigational Site Eden North Carolina 27288 —
Pfizer Investigational Site Winston-Salem North Carolina 27157 —
Pfizer Investigational Site Beachwood Ohio 44122 —
Pfizer Investigational Site Cincinnati Ohio 45219 —
Pfizer Investigational Site Cincinnati Ohio 45229 —
Pfizer Investigational Site Cincinnati Ohio 45246 —
Pfizer Investigational Site Cleveland Ohio 44106-5038 —
Pfizer Investigational Site Cleveland Ohio 44195 —
Pfizer Investigational Site Columbus Ohio 43210 —
Pfizer Investigational Site Columbus Ohio 43221 —
Pfizer Investigational Site Kettering Ohio 45429-1221 —
Pfizer Investigational Site Lorain Ohio 44053 —
Pfizer Investigational Site Sandusky Ohio 44870 —
Pfizer Investigational Site Oklahoma City Oklahoma 73104 —
Pfizer Investigational Site Tulsa Oklahoma 74133 —
Pfizer Investigational Site Tulsa Oklahoma 74136-1920 —
Pfizer Investigational Site Tulsa Oklahoma 74136 —
Pfizer Investigational Site Eugene Oregon 97401 —
Pfizer Investigational Site Portland Oregon 97210 —
Pfizer Investigational Site Portland Oregon 97216 —
Pfizer Investigational Site Allentown Pennsylvania 18102 —
Pfizer Investigational Site Allentown Pennsylvania 18106-0880 —
Pfizer Investigational Site Lansdale Pennsylvania 19446 —
Pfizer Investigational Site Lehighton Pennsylvania 18235 —
Pfizer Investigational Site Philadelphia Pennsylvania 19104 —
Pfizer Investigational Site Philadelphia Pennsylvania 19107 —
Pfizer Investigational Site Pittsburgh Pennsylvania 15213 —
Pfizer Investigational Site Sellersville Pennsylvania 18960 —
Pfizer Investigational Site Pawtucket Rhode Island 02860 —
Pfizer Investigational Site Providence Rhode Island 02906 —
Pfizer Investigational Site Charleston South Carolina 29403 —
Pfizer Investigational Site Sioux Falls South Dakota 57105 —
Pfizer Investigational Site Sioux Falls South Dakota 57108 —
Pfizer Investigational Site Memphis Tennessee 38104 —
Pfizer Investigational Site Memphis Tennessee 38105 —
Pfizer Investigational Site Memphis Tennessee 38119-5209 —
Pfizer Investigational Site Memphis Tennessee 38128 —
Pfizer Investigational Site Nashville Tennessee 37205 —
Pfizer Investigational Site Nashville Tennessee 37232-6300 —
Pfizer Investigational Site Austin Texas 78756 —
Pfizer Investigational Site Dallas Texas 75235 —
Pfizer Investigational Site Dallas Texas 75246 —
Pfizer Investigational Site Dallas Texas 75390-9047 —
Pfizer Investigational Site Denton Texas 76204 —
Pfizer Investigational Site Houston Texas 77030 —
Pfizer Investigational Site Lackland Air Force Base Texas 78236-5300 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Salt Lake City Utah 84124 —
Pfizer Investigational Site Burlington Vermont 05401 —
Pfizer Investigational Site Richmond Virginia 23249 —
Pfizer Investigational Site Richmond Virginia 23298 —
Pfizer Investigational Site Seattle Washington 98104 —
Pfizer Investigational Site Milwaukee Wisconsin 53295 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 133 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00327691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 3, 2007 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00327691 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →